Yervoy (ipilimumab) - BMS
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
Delayed inflammatory chorioretinopathy with VKH-like features and bilateral choroidal neovascularization after nivolumab-ipilimumab dual checkpoint blockade for metastatic melanoma. (PubMed, Arch Soc Esp Oftalmol (Engl Ed)) - Sep 22, 2026 - "Combined therapy achieved partial anatomical improvement but limited functional visual recovery, particularly in the initially symptomatic eye. In conclusion, this case highlights that ICI-associated inflammatory chorioretinopathy with VKH-like features may present late and progress despite treatment discontinuation, underscoring the role of multimodal imaging in guiding targeted management." 
Checkpoint inhibition • Journal • Cutaneous Melanoma • Melanoma • Ocular Inflammation • Oncology • Ophthalmology • Retinal Disorders • Solid Tumor • Uveitis
http://www.ncbi.nlm.nih.gov/pubmed/42767603
 
Á Martínez Sobrino; S Pastor-Idoate; T Stalmashka
 
Sep 22, 2026
 
Prev Next